Vera Therapeutics（NASDAQ:VERA）報告季度每股虧損爲 $(2.75)，這比分析師一致預估的 $(2.83) 高出2.83%。與去年同期每股虧損 $(2.25) 相比，這一數字下降了22.22%。

以上內容來自Benzinga Earnings專欄，原文如下：

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(2.75) per share which beat the analyst consensus estimate of $(2.83) by 2.83 percent. This is a 22.22 percent decrease over losses of $(2.25) per share from the same period last year.